Gene Garrard Olinger, Jr

Title: Gene Garrard Olinger, Jr.: Innovator in Filovirus Treatment

Introduction

Gene Garrard Olinger, Jr. is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of medical research, particularly in the treatment of filovirus-mediated diseases. With a total of 3 patents, Olinger has focused on developing innovative solutions to combat serious viral infections.

Latest Patents

Olinger's latest patents include groundbreaking work on compositions and methods for the treatment of filovirus-mediated diseases. This invention features compositions, methods, and kits that are useful for treating hemorrhagic fever caused by the Ebola virus in animals. Another significant patent involves immunogenic compositions and vaccines for Ebola. This patent describes a method and composition that utilizes CTL epitopes from various Ebola virion proteins to induce a protective immune response against the virus.

Career Highlights

Throughout his career, Gene Garrard Olinger, Jr. has worked with esteemed organizations, including the U.S. Government as represented by the Secretary of the Army and the U.S. Army Medical Research and Material Command. His work has been instrumental in advancing the understanding and treatment of viral diseases.

Collaborations

Olinger has collaborated with several professionals in his field, including Michael Adam Bailey and Lisa M. Johansen. These collaborations have contributed to the development of his innovative patents and research.

Conclusion

Gene Garrard Olinger, Jr. is a prominent figure in the field of medical innovation, particularly in the fight against filovirus-mediated diseases. His patents and career achievements reflect his dedication to improving public health through scientific research and innovation.